The Role of Verbal Peer Feedback in the Police: A Scoping Review

Authors: Dahl, Olav (ORCID 0000-0002-0039-843X), Damen, Marie-Louise, Bjørkelo, Brita, Meling, Camilla Pellegrini, Jensen, Magnus Rom

Source: Vocations and Learning. Jul 2023 16(2):227-250.

Peer Reviewed: Y

Page Count: 24

Descriptors: Police, Peer Evaluation, Feedback (Response), Peer Influence, Verbal Communication, Work Environment, Peer Relationship, Workplace Learning, Performance, Motivation, Job Satisfaction

ESHO 1–85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic Oncology

Authors: Overgaard, Jens, CCM Hulshof, Maarten, Dahl, Olav, Arcangeli, Giorgio

Source: In Radiotherapy and Oncology July 2024 196

ESHO 2-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology.

Authors: Overgaard, Jens¹ jens@oncology.au.dk, Dahl, Olav^2,3, Arcangeli, Giorgio⁴

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p943-949. 7p.

Subject Terms: *HEAD & neck cancer treatment, *HEAD & neck cancer, *STATISTICAL sampling, *FEVER, *TREATMENT effectiveness, *RANDOMIZED controlled trials, *DESCRIPTIVE statistics, *RADIATION dosimetry, *DISEASES, *COMBINED modality therapy, *RESEARCH methodology, *PAIN, *RADIATION doses, *TEMPERATURE, *COMPARATIVE studies, *QUALITY assurance

A study of microRNAs as new prognostic biomarkers in anal cancer patients.

Authors: Dahl, Olav^1,2 olav.dahl@helse-bergen.no, Myklebust, Mette Pernille¹

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p456-465. 10p.

Subject Terms: *RNA analysis, *MICRORNA, *TUMOR markers, *CANCER patients, *DESCRIPTIVE statistics, *GENE expression, *KAPLAN-Meier estimator, *ANAL tumors, *TUMOR classification, *PROGRESSION-free survival, *DATA analysis software, *CONFIDENCE intervals, *SEQUENCE analysis, *DISEASE progression, *TIME

Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors

Authors: Fjæra, Lars Fredrik, Indelicato, Daniel J., Ytre-Hauge, Kristian S., Muren, Ludvig P., Lassen-Ramshad, Yasmin, Toussaint, Laura, Dahl, Olav, Stokkevåg, Camilla H.

Source: In Advances in Radiation Oncology January-February 2021 6(1)

Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer

Authors: Hestetun, Kjersti Elvestad, Aasebø, Kristine, Rosenlund, Nina Benedikte, Müller, Yvonne, Dahl, Olav, Myklebust, Mette Pernille

Source: In Modern Pathology January 2021 34(1):161-170

miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.

Authors: Thor, Anna, Myklebust, Mette Pernille, Grenabo Bergdahl, Anna, Lundgren, Per-Olof, Skokic, Viktor, Almås, Bjarte, Haugnes, Hege Sagstuen, Tandstad, Torgrim, Akre, Olof, Cohn-Cedermark, Gabriella, Dahl, Olav, Kjellman, Anders

Source: Journal of Urology; Nov2024, Vol. 212 Issue 5, p720-730, 11p

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Authors: Ekanger, Christian, Helle, Svein Inge, Heinrich, Daniel, Johannessen, Dag Clement, Karlsdóttir, Ása, Nygård, Yngve, Halvorsen, Ole Johan, Reisæter, Lars, Kvåle, Rune, Hysing, Liv Bolstad, Dahl, Olav

Source: In Advances in Radiation Oncology May-June 2020 5(3):396-403

Watch your steps, especially when changing treatment for locally advanced rectal cancer

Authors: Dahl, Olav

Source: Acta oncologica. 61(9):1033-1035

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164797448.0x000001&indx=1&recIds=ETOCvdc_100164797448.0x000001

Optic nerve constraints for carbon ion RT at CNAO – Reporting and relating outcome to European and Japanese RBE

Authors: Dale, Jon Espen, Molinelli, Silvia, Vitolo, Viviana, Vischioni, Barbara, Bonora, Maria, Magro, Giuseppe, Pettersen, Helge Egil Seime, Mairani, Andrea, Hasegawa, Azusa, Dahl, Olav, Valvo, Francesca, Fossati, Piero

Source: In Radiotherapy and Oncology November 2019 140:175-181

Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

Authors: Dahl, Olav, Myklebust, Mette Pernille, Dale, Jon Espen, Leon, Otilia, Serup-Hansen, Eva, Jakobsen, Anders, Pfeiffer, Per, Løes, Inger Marie, Pfeffer, Frank, Spindler, Karen-Lise Garm, Guren, Marianne Grønlie, Glimelius, Bengt, Johnsson, Anders

Source: Acta oncologica. 59(9):1016-1023

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115554502.0x000001&indx=1&recIds=ETOCvdc_100115554502.0x000001

Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016

Authors: Guren, Marianne Grønlie, Aagnes, Bjarte, Nygård, Mari, Dahl, Olav, Møller, Bjørn

Source: In Clinical Colorectal Cancer March 2019 18(1):e96-e103

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors: Rekeland, Ingrid G., Sørland, Kari, Neteland, Lisbeth Lykke, Fosså, Alexander, Alme, Kine, Risa, Kristin, Dahl, Olav, Tronstad, Karl J., Mella, Olav, Fluge, Øystein

Source: PLoS ONE; 7/23/2024, Vol. 19 Issue 7, p1-20, 20p

Subject Terms: CHRONIC fatigue syndrome, RITUXIMAB, CLINICAL trials, CYCLOPHOSPHAMIDE, PHYSICAL mobility

Reply to M. Kamrava and F. Montorsi et al.

Authors: Ekanger, Christian, Helle, Svein Inge, Kvåle, Rune, Reisæter, Lars, Gravdal, Karsten, Honoré, Alfred, Dahl, Olav

Source: Journal of Clinical Oncology; 12/10/2024, Vol. 42 Issue 35, p4234-4235, 3p

The pioneers behind immune checkpoint blockers awarded the Nobel Prize in physiology or medicine 2018

Authors: Dahl, Olav, Brydøy, Marianne

Source: Acta oncologica. 58(1):1-8

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100098006363.0x000001&indx=1&recIds=ETOCvdc_100098006363.0x000001

Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment

Authors: Dahl, Olav, Dale, Jon Espen, Brydøy, Marianne

Source: Acta oncologica. 58(1):9-20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100098006358.0x000001&indx=1&recIds=ETOCvdc_100098006358.0x000001

Risk of carotid blowout after reirradiation with particle therapy

Authors: Dale, Jon Espen, Molinelli, Silvia, Ciurlia, Elisa, Ciocca, Mario, Bonora, Maria, Vitolo, Viviana, Mirandola, Alfredo, Russo, Stefania, Orecchia, Roberto, Dahl, Olav, Fossati, Piero

Source: In Advances in Radiation Oncology July-September 2017 2(3):465-474

Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up.

Authors: Ekanger, Christian, Helle, Svein Inge, Reisæter, Lars, Hysing, Liv Bolstad, Kvåle, Rune, Honoré, Alfred, Gravdal, Karsten, Pilskog, Sara, Dahl, Olav

Source: Journal of Clinical Oncology; 2024 Supplement 16, Vol. 42, p1934-1942, 10p

A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer

Authors: Jacob, Havjin, Stanisavljevic, Luka, Storli, Kristian, Hestetun, Kjersti, Dahl, Olav, Myklebust, Mette

Source: Scientific reports. 8(1):1-9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132431301.0x000001&indx=1&recIds=ETOCvdc_100132431301.0x000001

Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study

Authors: Haugnes, Hege S., Stenklev, Niels Christian, Brydøy, Marianne, Dahl, Olav, Wilsgaard, Tom, Laukli, Einar, Fosså, Sophie D.

Source: Acta oncologica. 57(8):1075-1083

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100104516247.0x000001&indx=1&recIds=ETOCvdc_100104516247.0x000001